TrialAmerican journal of respiratory and critical care medicine2020

Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease.

David A Lipson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.